1. Home
  2. BWBBP vs GNLX Comparison

BWBBP vs GNLX Comparison

Compare BWBBP & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgewater Bancshares Inc.

BWBBP

Bridgewater Bancshares Inc.

N/A

Current Price

$19.19

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$4.17

Market Cap

202.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWBBP
GNLX
Founded
N/A
2001
Country
United States
United States
Employees
325
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
202.4M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
BWBBP
GNLX
Price
$19.19
$4.17
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$19.75
AVG Volume (30 Days)
N/A
157.5K
Earning Date
N/A
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$1.99
52 Week High
N/A
$8.54

Technical Indicators

Market Signals
Indicator
BWBBP
GNLX
Relative Strength Index (RSI) 41.43 35.32
Support Level $18.76 $4.00
Resistance Level $20.10 $4.37
Average True Range (ATR) 0.24 0.32
MACD -0.10 -0.01
Stochastic Oscillator 32.09 13.94

Price Performance

Historical Comparison
BWBBP
GNLX

About BWBBP Bridgewater Bancshares Inc.

Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: